ECKERT+ZIEGLER INH O.N. (EUZ.DE) Financials
EUZ.DE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
March 31, 2024 | 456.5 million | 219.5 million |
Dec. 31, 2023 | 439.4 million | 215.3 million |
Sept. 30, 2023 | 443.5 million | 218.5 million |
June 30, 2023 | 433.1 million | 219.3 million |
EUZ.DE Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
March 31, 2024 | -596000 | ? |
Dec. 31, 2023 | 16.2 million | 3.1 million |
Sept. 30, 2023 | 2.1 million | ? |
June 30, 2023 | 4.5 million | ? |
EUZ.DE Net Income
Date | Net Income |
---|---|
March 31, 2024 | 9.0 million |
Dec. 31, 2023 | 9.9 million |
Sept. 30, 2023 | 9.6 million |
June 30, 2023 | 6.3 million |
EUZ.DE Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
March 31, 2024 | 66.3 million | - | 31.2 million |
Dec. 31, 2023 | 68.0 million | - | 29.9 million |
Sept. 30, 2023 | 88.4 million | - | 25.3 million |
June 30, 2023 | 77.1 million | 47.0 million | 25.6 million |
EUZ.DE Shares Outstanding
EUZ.DE Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
March 31, 2024 | 4.3 million | - | 11.5 million | 6.2 million |
Dec. 31, 2023 | 6.6 million | - | 16.3 million | 8.4 million |
Sept. 30, 2023 | 7.5 million | - | 10.8 million | 6.4 million |
June 30, 2023 | 7.2 million | - | 10.0 million | 6.6 million |
EUZ.DE Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
March 31, 2024 | 67.6 million | 32.7 million |
Dec. 31, 2023 | 62.2 million | 35.7 million |
Sept. 30, 2023 | 65.9 million | 33.4 million |
June 30, 2023 | 60.0 million | 30.1 million |
EUZ.DE
Price: €44.84
Dividend Yield: 1.08%
Forward Dividend Yield: 1.12%
Payout Ratio: 34.25%
Dividend Per Share: 0.50 EUR
Earnings Per Share: 1.66 EUR
P/E Ratio: 27.70
Exchange: GER
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 958.5 million
Average Dividend Frequency: 1
Years Paying Dividends: 20
DGR3: -22.57%
DGR5: 30.00%
DGR10: 30.00%